UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Turquoise infrastructure: Assessing the impacts of global change on multi-habitat connectivity from a landscape management perspective

Landscape and urban planning, 2024-05, Vol.245, p.105016, Article 105016

2024

Volltextzugriff (PDF)

Sex determination: the amphibian models

Reproduction, nutrition, development, 2004-11, Vol.44 (6), p.539-549

EGGERT, Christophe

2004

Volltextzugriff (PDF)

Fossorial but widespread: the phylogeography of the common spadefoot toad (Pelobates fuscus), and the role of the Po Valley as a major source of genetic variability

Molecular ecology, 2007-07, Vol.16 (13), p.2734-2754

2007

Volltextzugriff (PDF)

Reproductive behaviour of spadefoot toads ( Pelobates fuscus ): daily sex ratios and males' tactics, ages, and physical condition

Canadian journal of zoology, 2003-01, Vol.81 (1), p.46-51

2003

Volltextzugriff (PDF)

The declining Spadefoot toad, Pelobates fuscus (Pelobatidae): paleo and recent environmental changes as a major influence on current population structure and status

Conservation genetics, 2006-04, Vol.7 (2), p.185-195

2006

Volltextzugriff (PDF)

The declining Spadefoot toad, Pelobates fuscus (Pelobatidae): paleo and recent environmental changes as a major influence on current population structureand status

Conservation genetics, 2006-04, Vol.7 (2), p.185-195

2006

Volltextzugriff (PDF)

Le déclin du pélobate brun (Pelobates fuscus, Amphibien anoure) : De la biologie des populations à la structuration génétique

Bulletin de la Société zoologique de France, 2002, Vol.127 (3), p.273-279

EGGERT, Christophe

2002

Volltextzugriff (PDF)

Age Structure of a Spadefoot Toad Pelobates fuscus (Pelobatidae) Population

Copeia, 1999-12, Vol.1999 (4), p.1127

1999

Volltextzugriff (PDF)

A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease

Movement disorders, 2016-09, Vol.31 (9), p.1373-1380

2016

Volltextzugriff (PDF)

Did human activity really trigger the late Holocene rainforest crisis in Central Africa?

Proceedings of the National Academy of Sciences - PNAS, 2018-05, Vol.115 (21), p.E4733-E4734

2018

Volltextzugriff (PDF)

Trial of Prasinezumab in Early-Stage Parkinson’s Disease

The New England journal of medicine, 2022-08, Vol.387 (5), p.421-432

2022

Volltextzugriff (PDF)

Multi-omics analysis to evaluate the effects of solar exposure and a broad-spectrum SPF50+ sunscreen on markers of skin barrier function in a skin ecosystem model

Photochemistry and photobiology, 2024-07

2024

Volltextzugriff (PDF)

Detection of plasticity mechanisms in molecular dynamics: Application to TATB single crystal

AIP Conference Proceedings, 2018, Vol.1979 (1)

2018

Volltextzugriff (PDF)

Machine-learning based potential for iron: Plasticity and phase transition

AIP Conference Proceedings, 2018, Vol.1979 (1)

2018

Volltextzugriff (PDF)

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data

Frontiers in neurology, 2021-10, Vol.12, p.705407-705407

2021

Volltextzugriff (PDF)

Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

Nature medicine, 2023-11, Vol.29 (11), p.2955-2956

2023

Volltextzugriff (PDF)

Effects of ZrCuAl bulk metallic glasses Poisson’s ratios on spalling process induced by laser shock

AIP Conference Proceedings, 2018, Vol.1979 (1)

2018

Volltextzugriff (PDF)

The LifeTime initiative: Towards cell-based medicine in Europe

Nature (London), 2020-11, Vol.587 (7834), p.377-386

2020

Volltextzugriff (PDF)

Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression

Frontiers in neuroscience, 2021-12, Vol.15, p.765765-765765

2021

Volltextzugriff (PDF)

A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease: Dipraglurant in Levodopa-Induced Dyskinesia

Movement disorders, 2016-09, Vol.31 (9), p.1373-1380

2016

Volltextzugriff (PDF)

Inklusive Medienbildung in einer mediatisierten Welt: Medienpädagogische Perspektiven auf ein interprofessionelles Forschungsfeld

2024

Volltextzugriff (PDF)

Safety, Tolerability and Anti-Dyskinetic Efficacy of Dipraglurant, a Novel mGluR5 Negative Allosteric Modulator (NAM) in Parkinson's Disease (PD) Patients with Levodopa-Induced Dyskinesia (LID) (S23.004)

Neurology, 2013-02, Vol.80 (7_supplement)

2013

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

ThemaHumanities And Social Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Turquoise infrastructure: Assessing the impacts of global change on multi-habitat connectivity from a landscape management perspective

Sex determination: the amphibian models

Fossorial but widespread: the phylogeography of the common spadefoot toad (Pelobates fuscus), and the role of the Po Valley as a major source of genetic variability

Reproductive behaviour of spadefoot toads ( Pelobates fuscus ): daily sex ratios and males' tactics, ages, and physical condition

The declining Spadefoot toad, Pelobates fuscus (Pelobatidae): paleo and recent environmental changes as a major influence on current population structure and status

The declining Spadefoot toad, Pelobates fuscus (Pelobatidae): paleo and recent environmental changes as a major influence on current population structureand status

Le déclin du pélobate brun (Pelobates fuscus, Amphibien anoure) : De la biologie des populations à la structuration génétique

Age Structure of a Spadefoot Toad Pelobates fuscus (Pelobatidae) Population

A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease

Did human activity really trigger the late Holocene rainforest crisis in Central Africa?

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

Trial of Prasinezumab in Early-Stage Parkinson’s Disease

Multi-omics analysis to evaluate the effects of solar exposure and a broad-spectrum SPF50+ sunscreen on markers of skin barrier function in a skin ecosystem model

Detection of plasticity mechanisms in molecular dynamics: Application to TATB single crystal

A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia

Machine-learning based potential for iron: Plasticity and phase transition

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data

Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

Effects of ZrCuAl bulk metallic glasses Poisson’s ratios on spalling process induced by laser shock

The LifeTime initiative: Towards cell-based medicine in Europe

Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression

A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease: Dipraglurant in Levodopa-Induced Dyskinesia

Inklusive Medienbildung in einer mediatisierten Welt: Medienpädagogische Perspektiven auf ein interprofessionelles Forschungsfeld

Safety, Tolerability and Anti-Dyskinetic Efficacy of Dipraglurant, a Novel mGluR5 Negative Allosteric Modulator (NAM) in Parkinson's Disease (PD) Patients with Levodopa-Induced Dyskinesia (LID) (S23.004)

A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia: AQW051 in Levodopa-Induced Dyskinesia

Aktive Filter

Suchergebnisse filtern